Pinnbrook Capital Management LP Makes New Investment in Danaher Corporation $DHR

Pinnbrook Capital Management LP acquired a new position in Danaher Corporation (NYSE:DHR) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 43,387 shares of the conglomerate’s stock, valued at approximately $9,932,000. Danaher makes up about 1.4% of Pinnbrook Capital Management LP’s investment portfolio, making the stock its 20th biggest position.

A number of other institutional investors and hedge funds also recently bought and sold shares of DHR. JPL Wealth Management LLC acquired a new position in Danaher in the third quarter worth $25,000. Elevated Capital Advisors LLC acquired a new position in Danaher in the fourth quarter worth $26,000. WFA of San Diego LLC acquired a new position in Danaher in the second quarter worth $26,000. ANTIPODES PARTNERS Ltd acquired a new position in Danaher in the third quarter worth $27,000. Finally, Financial Life Planners acquired a new position in Danaher in the third quarter worth $32,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have commented on DHR. UBS Group reduced their price objective on Danaher from $270.00 to $250.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. Wells Fargo & Company dropped their target price on Danaher from $240.00 to $212.00 and set an “equal weight” rating for the company in a research report on Wednesday, April 22nd. Guggenheim dropped their target price on Danaher from $275.00 to $235.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. KeyCorp restated an “overweight” rating on shares of Danaher in a research report on Thursday, January 29th. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Danaher in a research report on Thursday, January 29th. Nineteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $238.65.

Danaher Trading Up 1.4%

DHR stock opened at $173.51 on Friday. The company has a market cap of $122.80 billion, a P/E ratio of 33.56, a PEG ratio of 2.29 and a beta of 0.81. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The business has a fifty day moving average of $183.98 and a 200-day moving average of $208.99.

Danaher (NYSE:DHR) last released its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. The company had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The firm’s quarterly revenue was up 3.7% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.88 earnings per share. As a group, equities research analysts expect that Danaher Corporation will post 8.43 EPS for the current year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio is currently 30.95%.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.